EFFECT OF TREATMENT WITH TRIMETAZIDINE ON INDICATORS OF EXERCISE TOLERANCE AND QUALITY OF LIFE OF PATIENTS WITH STABLE ANGINA RECEIVING OPTIMAL DRUG THERAPY


M.V. Novikova (1), M.G. Glezer (1, 2)

(1) SBI "City Clinical Hospital № 59", Moscow; (2) SBEI HPE "First MSMU n.a. I.M. Sechenov" of RMPH, Moscow
The article presents the results of evaluation of antianginal and anti-ischemic efficacy of long-acting trimetazidine generic (Angiozil retard) involving 21 patients with stable angina and stable positive exercise treadmill test. Treatment with trimetazidine at a daily dose of 70 mg was conducted over four months. It has been shown that the addition of trimetazidine to the background therapy of patients with stable angina improves the clinical course of the disease. Increasing the duration of treatment increases the effectiveness of treatment.

About the Autors


M.V. Novikova – SBI "City Clinical Hospital № 59", Moscow
M.G. Glezer – SBI "City Clinical Hospital № 59", Moscow, SBEI HPE "First MSMU n.a. I.M. Sechenov" of RMPH, Moscow


Similar Articles


Бионика Медиа